DoctorateOpen Access

Semi-synthesis of astragenol derivatives and their biological activities

Is this your thesis?

This record came from a bulk archive import. If it’s yours, link it to your profile.

Abstract (EN)

After recognizing as potent tumor inhibitors, saponins have suddenly become one of the primary targets for new pharmacologically active anti-tumor molecules. Semi-synthetic anticancer drug discovery programs focusing on saponins mainly engaged with commercially available triterpenoids. However, studies on the preparation of analogues of Astragalus cycloartanes have so far been limited. Therefore, the exploration of new anti-cancer agents prepared from cycloastragenol and cyclocanthagenol via semi-synthesis studies. In this study, extraction conditions were optimized to achieve highest yield of Astragaloside IV, Astragaloside VII, cyclocanthagenol and cycloastragenol from Astragalus trojanus. Forty semi-synthetic derivatives from the isolated aglycones (cyclocanthagenol and cycloastragenol) were prepared by oxidation, esterification, alkylation, elimination and condensation reactions. The compounds were screened for their cytotoxicities against four different cancer cell lines (human prostate cancer cell lines: PC-3 and DU-145; human colon adenocarcinoma: HT-29; human breast adenocarcinoma: MDA-MB- 231). Sixteen out of 38 molecules were established to be more active than the starting compound CG. Three molecules on PC-3 cell line; 1 molecule on DU-145 cell line; 1 molecule on HT-29 cell line and 4 molecules on MDA-MB- 231 cell line exhibited IC50 values lower than 10 µM.

Author

Özgür Tağ

How to Cite

Özgür Tağ (Doctorate thesis). Semi-synthesis of astragenol derivatives and their biological activities, 2016, Ege University.

Keywords

License

Tüm Hakları Saklıdır

This work is shared under the specified license terms.

More theses from Ege University